{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:55:24Z","timestamp":1772218524732,"version":"3.50.1"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejim.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:03:46Z","timestamp":1686881026000},"page":"23-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"114","author":[{"given":"Hang","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong-Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105375","article-title":"Nonalcoholic fatty liver disease (nafld). Mitochondria as players and targets of therapies?","volume":"22","author":"Di Ciaula","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.06.011_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S80364","article-title":"Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study","volume":"8","author":"Lesmana","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3748\/wjg.v16.i2.143","article-title":"Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment","volume":"16","author":"Ponziani","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0007","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5152\/tjg.2022.211022","article-title":"Metabolic disorders and risk of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"23","key":"10.1016\/j.ejim.2023.06.011_bib0008","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMra010076","article-title":"Mesenteric venous thrombosis","volume":"345","author":"Kumar","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2014.08.032","article-title":"Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis","volume":"62","author":"Turon","year":"2015","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4254\/wjh.v8.i7.376","article-title":"Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list","volume":"8","author":"Basaranoglu","year":"2016","journal-title":"World J Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0011","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0012","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/MEG.0000000000001689","article-title":"Association between nonalcoholic fatty liver disease and portal vein thrombosis: a systematic review and meta-analysis","volume":"32","author":"Lin","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.06.011_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2020.12.002","article-title":"Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease","volume":"198","author":"Ciavarella","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2023.06.011_bib0014","article-title":"De novo portal vein thrombosis in non-cirrhotic non-alcoholic fatty liver disease: a 9-year prospective cohort study","volume":"8","author":"Abdel-Razik","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis","volume":"9","author":"Stine","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"18","key":"10.1016\/j.ejim.2023.06.011_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810667","article-title":"Platelet hemostasis reactions at different temperatures correlate with intracellular calcium concentration","volume":"23","author":"Mindukshev","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0017","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2021.09.029","article-title":"Overlooked subclinical portal hypertension in non-cirrhotic nafld: is it real and how to measure it?","volume":"76","author":"Baffy","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0018","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0038-1646801","article-title":"Effects of adenosine diphosphate, colchicine and temperature on size of human platelets","volume":"41","author":"Laufer","year":"1979","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0019","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0038-1642766","article-title":"Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure","volume":"59","author":"Erne","year":"1988","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/hep.24721","article-title":"Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis","volume":"55","author":"Alkhouri","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/09537104.2012.688898","article-title":"Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease","volume":"24","author":"Celikbilek","year":"2013","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09537100903391023","article-title":"Mean platelet volume in patients with non-alcoholic fatty liver disease","volume":"21","author":"Ozhan","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.ejim.2023.06.011_bib0023","first-page":"75","article-title":"Comparison of platelet number and function between nonalcoholic fatty liver disease and normal individuals","volume":"22","author":"Saremi","year":"2017","journal-title":"J Res Med Sci"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0024","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/09537104.2010.540049","article-title":"The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese korean population","volume":"22","author":"Shin","year":"2011","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0025","first-page":"175","article-title":"Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease","volume":"52","author":"Das","year":"2011","journal-title":"Singapore Med J"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0026","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/03009734.2010.500062","article-title":"Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease","volume":"115","author":"Kilciler","year":"2010","journal-title":"Ups J Med Sci"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.011_bib0027","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1515\/cclm-2014-0303","article-title":"Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker?","volume":"52","author":"Kocabay","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MCG.0000000000000340","article-title":"Nonalcoholic fatty liver disease and mean platelet volume: a systemic review and meta-analysis","volume":"50","author":"Madan","year":"2016","journal-title":"J Clin Gastroenterol"},{"issue":"6390","key":"10.1016\/j.ejim.2023.06.011_bib0029","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.287.6390.456","article-title":"Changes in volume and density of platelets in myocardial infarction","volume":"287","author":"Martin","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-4804(03)00163-X","article-title":"Hepatic and mesenteric nitric oxide synthase expression in a rat model of ccl(4)-induced cirrhosis","volume":"113","author":"Bhimani","year":"2003","journal-title":"J Surg Res"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0031","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.06.011_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1755-8794-7-57","article-title":"Identification of co-expression gene networks, regulatory genes and pathways for obesity based on adipose tissue rna sequencing in a porcine model","volume":"7","author":"Kogelman","year":"2014","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12876-017-0592-y","article-title":"Non alcoholic fatty liver disease and enos dysfunction in humans","volume":"17","author":"Persico","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"16","key":"10.1016\/j.ejim.2023.06.011_bib0034","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/MCB.23.16.5726-5737.2003","article-title":"Activation of the phosphatidylinositol 3-kinase\/protein kinase akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis","volume":"23","author":"Kawasaki","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0035","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI3030","article-title":"Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action","volume":"102","author":"Shankar","year":"1998","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0036","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ejim.2023.06.011_bib0037","doi-asserted-by":"crossref","first-page":"41231","DOI":"10.1038\/srep41231","article-title":"Mechanistic interplay between ceramide and insulin resistance","volume":"7","author":"Reali","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0038","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1743-7075-8-25","article-title":"Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans","volume":"8","author":"Chen","year":"2011","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0039","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by pp2a-mediated dephosphorylation of the enos-akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1074\/jbc.M309552200","article-title":"Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells","volume":"279","author":"HD","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0041","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00281-013-0407-3","article-title":"Ceacam1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (nash)","volume":"36","author":"Najjar","year":"2014","journal-title":"Semin Immunopathol"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0042","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0168-8278(02)00266-0","article-title":"Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis","volume":"37","author":"Sanz-Cameno","year":"2002","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0043","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1160\/TH06-09-0498","article-title":"Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia\u2013effects of selective inducible nitric oxide synthase inhibition","volume":"97","author":"Matejovic","year":"2007","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0044","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0022-2275(20)33432-5","article-title":"Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans","volume":"41","author":"Elizalde","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2023.06.011_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.niox.2013.04.007","article-title":"Nitric oxide mediates the insulin sensitizing effects of beta-sitosterol in high fat diet-fed rats","volume":"32","author":"Radika","year":"2013","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejim.2023.06.011_bib0046","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jep.2019.03.006","article-title":"Protective effect and mechanism of qiwei tiexie capsule on 3t3-l1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating lxralpha, ppargamma, and nf-kappab-inos-no signaling pathways","volume":"236","author":"Suolang","year":"2019","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.011_bib0047","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2337\/db20-1228","article-title":"Critical role for hepatocyte-specific enos in nafld and nash","volume":"70","author":"Cunningham","year":"2021","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0048","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1872-034X.2009.00539.x","article-title":"Influence of inducible nitric oxide synthase polymorphisms in japanese patients with non-alcoholic fatty liver disease","volume":"39","author":"Yoneda","year":"2009","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0049","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.M051680","article-title":"Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis","volume":"56","author":"Shih","year":"2015","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0051","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","article-title":"The tmao-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance","volume":"10","author":"Warrier","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0052","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1038\/s41598-020-75633-1","article-title":"Trimethylamine n-oxide and the reverse cholesterol transport in cardiovascular disease: a cross-sectional study","volume":"10","author":"Bordoni","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0053","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1007\/s11033-022-07375-4","article-title":"Possible correlation between high circulatory levels of trimethylamine-n-oxide and 2177g>c polymorphisms of hepatic flavin containing monooxygenase 3 in kurdish population with non-alcoholic fatty liver disease","volume":"49","author":"Moradzad","year":"2022","journal-title":"Mol Biol Rep"},{"issue":"17","key":"10.1016\/j.ejim.2023.06.011_bib0054","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.116.025338","article-title":"Gut microbe-generated trimethylamine n-oxide from dietary choline is prothrombotic in subjects","volume":"135","author":"Zhu","year":"2017","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.ejim.2023.06.011_bib0055","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1016\/j.ejim.2023.06.011_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121971","article-title":"Trimethylamine-n-oxide (tmao) as novel potential biomarker of early predictors of metabolic syndrome","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ejim.2023.06.011_bib0057","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-n-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0058","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/liv.14963","article-title":"Circulating trimethylamine-n-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease","volume":"41","author":"Flores-Guerrero","year":"2021","journal-title":"Liver Int"},{"issue":"17","key":"10.1016\/j.ejim.2023.06.011_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900257","article-title":"Trimethylamine n-oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid x receptor signaling in nonalcoholic fatty liver disease","volume":"63","author":"Tan","year":"2019","journal-title":"Mol Nutr Food Res"},{"issue":"34","key":"10.1016\/j.ejim.2023.06.011_bib0060","doi-asserted-by":"crossref","first-page":"e27048","DOI":"10.1097\/MD.0000000000027048","article-title":"Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: a strobe-compliant article","volume":"100","author":"Lin","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2023.06.011_bib0061","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nutres.2022.02.004","article-title":"Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women","volume":"101","author":"Muzsik-Kazimierska","year":"2022","journal-title":"Nutr Res"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.011_bib0062","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine n-oxide levels in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0063","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite tmao enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ejim.2023.06.011_bib0064","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"issue":"7341","key":"10.1016\/j.ejim.2023.06.011_bib0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0066","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/MOH.0b013e328363c11f","article-title":"New development in von willebrand disease","volume":"20","author":"Castaman","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ejim.2023.06.011_bib0067","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619887437","article-title":"Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0068","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MBC.0000000000000009","article-title":"Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease","volume":"25","author":"Bilgir","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0069","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor viii, ix, xi and xii activities in non-alcoholic fatty liver disease","volume":"31","author":"Kotronen","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von willebrand factor, and adamts13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0071","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2016.06.001","article-title":"Preserved hemostatic status in patients with non-alcoholic fatty liver disease","volume":"65","author":"Potze","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0072","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0073","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit adamts13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0074","first-page":"675","article-title":"Hepatic steatosis causes induction of the chemokine rantes in the absence of significant hepatic inflammation","volume":"3","author":"Kirovski","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0463.2011.02746.x","article-title":"Microvesicular fat, inter cellular adhesion molecule-1 and regulatory t-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis","volume":"119","author":"Soderberg","year":"2011","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0076","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0077","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253298","article-title":"Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease","volume":"16","author":"Sukahri","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0078","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1464-5491.2004.01201.x","article-title":"Vascular endothelium and inflammatory process, in patients with combined type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin c","volume":"21","author":"Antoniades","year":"2004","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.011_bib0079","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/STROKEAHA.107.513150","article-title":"Blood cell-derived rantes mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion","volume":"39","author":"Terao","year":"2008","journal-title":"Stroke"},{"issue":"5663","key":"10.1016\/j.ejim.2023.06.011_bib0080","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0081","doi-asserted-by":"crossref","first-page":"14166","DOI":"10.1038\/s41598-018-32576-y","article-title":"Respiratory syncytial virus induces the classical ros-dependent netosis through pad-4 and necroptosis pathways activation","volume":"8","author":"Muraro","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0082","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","article-title":"Von willebrand factor directly interacts with dna from neutrophil extracellular traps","volume":"34","author":"Grassle","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0083","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1038\/s41598-020-60469-6","article-title":"Streptonigrin at low concentration promotes heterochromatin formation","volume":"10","author":"Loyola","year":"2020","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.ejim.2023.06.011_bib0084","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1301059110","article-title":"Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice","volume":"110","author":"Martinod","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"14","key":"10.1016\/j.ejim.2023.06.011_bib0086","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2014-06-582759","article-title":"Inter-alpha inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury","volume":"125","author":"Chaaban","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0087","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1038\/s41598-017-09337-4","article-title":"Cith3: a reliable blood biomarker for diagnosis and treatment of endotoxic shock","volume":"7","author":"Pan","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0088","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","article-title":"Neutrophil extracellular traps enriched with il-1beta and il-17a participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis","volume":"481","author":"Arelaki","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejim.2023.06.011_bib0089","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2020.11.003","article-title":"Nonalcoholic fatty liver disease (nafld) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets","volume":"231","author":"Miele","year":"2021","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0090","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.011_bib0091","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cgh.2012.05.008","article-title":"Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease","volume":"10","author":"Mendes","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0092","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.cgh.2018.12.038","article-title":"Patients with signs of advanced liver disease and clinically significant portal hypertension do not necessarily have cirrhosis","volume":"17","author":"Rodrigues","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0093","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","article-title":"Mechanical stretch increases expression of cxcl1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension","volume":"157","author":"Hilscher","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2023.06.011_bib0094","doi-asserted-by":"crossref","first-page":"42577","DOI":"10.1038\/srep42577","article-title":"The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma","volume":"7","author":"Hsieh","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ijo.2010.134","article-title":"Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic nafld-related portal hypertension","volume":"35","author":"Francque","year":"2011","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0096","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jhep.2020.10.011","article-title":"Patients with nafld do not have severe portal hypertension in the absence of cirrhosis","volume":"74","author":"Moga","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0097","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MEG.0000000000000825","article-title":"Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis","volume":"29","author":"Sourianarayanane","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0098","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials","volume":"70","author":"Sanyal","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0099","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of hvpg measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.14218\/JCTH.2021.00593","article-title":"Portal hypertension in nonalcoholic fatty liver disease: from pathogenesis to clinical practice","volume":"10","author":"Nababan","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0101","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/etm.2013.1239","article-title":"Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in budd-chiari syndrome complicated by thrombosis","volume":"6","author":"Zhang","year":"2013","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.coph.2004.10.003","article-title":"Hypercoagulability in the metabolic syndrome","volume":"5","author":"Nieuwdorp","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0103","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","author":"Tripodi","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S0007114519002484","article-title":"Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease","volume":"123","author":"Cerletti","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ejim.2023.06.011_bib0106","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2015.04.004","article-title":"Decreased plasma endogenous soluble rage, and enhanced adipokine secretion, oxidative stress and platelet\/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and\/or metabolic syndrome","volume":"72","author":"Santilli","year":"2015","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0107","first-page":"1640","article-title":"Isolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.011_bib0108","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0109","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41598-018-19889-8","article-title":"Tissue factor-bearing mps and the risk of venous thrombosis in cancer patients: a meta-analysis","volume":"8","author":"Cui","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2011.03.009","article-title":"Pparalpha activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and nash","volume":"218","author":"Baron","year":"2011","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0111","first-page":"261","article-title":"Dynamics of circulating microparticles in liver transplant patients","volume":"17","author":"Brodsky","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2-3","key":"10.1016\/j.ejim.2023.06.011_bib0112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0021-9150(92)90015-9","article-title":"Lipolysis of triglyceride-rich lipoproteins activates coagulant factor xii: a study in familial lipoprotein-lipase deficiency","volume":"95","author":"Mitropoulos","year":"1992","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3343\/alm.2015.35.1.15","article-title":"Influence of blood lipids on global coagulation test results","volume":"35","author":"Kim","year":"2015","journal-title":"Ann Lab Med"},{"issue":"37","key":"10.1016\/j.ejim.2023.06.011_bib0114","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.3748\/wjg.v11.i37.5834","article-title":"Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases","volume":"11","author":"Assy","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1650524","article-title":"Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men\u2013role of the metabolic syndrome","volume":"76","author":"Cigolini","year":"1996","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1665-2681(19)31746-6","article-title":"Altered clot kinetics in patients with non-alcoholic fatty liver disease","volume":"8","author":"Hickman","year":"2009","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0117","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1160\/TH16-09-0716","article-title":"Obesity\/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans","volume":"117","author":"Lallukka","year":"2017","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.011_bib0118","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2009.06.023","article-title":"Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease","volume":"51","author":"Papatheodoridis","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2023.06.011_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2019.107813","article-title":"A novel polysaccharide from malus halliana koehne with coagulant activity","volume":"485","author":"Zhang","year":"2019","journal-title":"Carbohydr Res"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0120","doi-asserted-by":"crossref","first-page":"e4581","DOI":"10.1371\/journal.pntd.0004581","article-title":"A deep insight into the sialome of rhodnius neglectus, a vector of chagas disease","volume":"10","author":"Santiago","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0121","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc08-0282","article-title":"Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome","volume":"31","author":"Undas","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0122","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0735-1097(95)00518-8","article-title":"Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes","volume":"27","author":"Aoki","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0123","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.96.7.2262","article-title":"Advanced glycation end product (age)-mediated induction of tissue factor in cultured endothelial cells is dependent on rage","volume":"96","author":"Bierhaus","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0124","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/db09-1008","article-title":"Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin","volume":"59","author":"Gerrits","year":"2010","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.011_bib0125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00401055","article-title":"Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects","volume":"36","author":"Ceriello","year":"1993","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0126","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/CCM.0000000000005467","article-title":"Acquired von willebrand syndrome and desmopressin resistance during venovenous extracorporeal membrane oxygenation in patients with covid-19: a prospective observational study","volume":"50","author":"Kalbhenn","year":"2022","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.011_bib0127","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1111\/jcmm.15321","article-title":"Antiphospholipid antibody-activated nets exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome","volume":"24","author":"Lu","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190728","article-title":"Histological comparison of arterial thrombi in mice and men and the influence of cl-amidine on thrombus formation","volume":"13","author":"Novotny","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0129","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V89.7.2429","article-title":"Apoptotic vascular endothelial cells become procoagulant","volume":"89","author":"Bombeli","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0131","first-page":"e3585","article-title":"Fibrin breakdown assay","volume":"10","author":"Ling","year":"2020","journal-title":"Bio Protoc."},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","article-title":"Pai-1 gene 4\u00a0g\/5\u00a0g genotype: a risk factor for thrombosis in vessels of internal organs","volume":"71","author":"Balta","year":"2002","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0134","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cld.2016.12.003","article-title":"Coagulopathy before and after liver transplantation: from the hepatic to the systemic circulatory systems","volume":"21","author":"Stine","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0135","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"Nash predicts plasma inflammatory biomarkers independently of visceral fat in men","volume":"16","author":"Targher","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0136","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","article-title":"Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.011_bib0137","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.011_bib0139","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/BF03349221","article-title":"Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis","volume":"30","author":"Yener","year":"2007","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.12705","article-title":"Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders","volume":"30","author":"Chang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0141","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children","volume":"50","author":"Alisi","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0142","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ijpo.12183","article-title":"Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease","volume":"13","author":"Jin","year":"2018","journal-title":"Pediatr Obes"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.011_bib0143","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma pai-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"52","key":"10.1016\/j.ejim.2023.06.011_bib0144","doi-asserted-by":"crossref","first-page":"89746","DOI":"10.18632\/oncotarget.21120","article-title":"Tm5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejim.2023.06.011_bib0145","article-title":"Screening new blood indicators for non-alcoholic fatty liver disease (nafld) diagnosis of chinese based on machine learning","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"42","key":"10.1016\/j.ejim.2023.06.011_bib0146","doi-asserted-by":"crossref","first-page":"27176","DOI":"10.1074\/jbc.273.42.27176","article-title":"Nesheim ME. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0147","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/labmed\/lmw023","article-title":"A case of unexplained cerebral sinus thrombosis in a 22-year-old obese caucasian woman","volume":"47","author":"Seheult","year":"2016","journal-title":"Lab Med"},{"issue":"21","key":"10.1016\/j.ejim.2023.06.011_bib0148","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10214906","article-title":"Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: a pilot study","volume":"10","author":"Gidaro","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2023.06.011_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2022.02.023","article-title":"Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease","volume":"213","author":"Eriksen","year":"2022","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.011_bib0151","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2006.112094","article-title":"Benefits of lifestyle modification in nafld","volume":"56","author":"Harrison","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.011_bib0152","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0033-1334866","article-title":"Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic\/thrombotic and vascular complications","volume":"39","author":"Targher","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0153","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1016\/j.thromres.2013.02.014","article-title":"Beneficial effects of habitual resistance exercise training on coagulation and fibrinolytic responses","volume":"131","author":"Kupchak","year":"2013","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.011_bib0154","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00007256-200434030-00004","article-title":"Exercise and training effects on blood haemostasis in health and disease: an update","volume":"34","author":"El-Sayed","year":"2004","journal-title":"Sports Med"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.011_bib0155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jvs.2004.07.030","article-title":"Exercise training enhances endogenous fibrinolysis in peripheral arterial disease","volume":"40","author":"Killewich","year":"2004","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.011_bib0156","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00421-014-2857-2","article-title":"Age and aerobic training status effects on plasma and skeletal muscle tpa and pai-1","volume":"114","author":"Francis","year":"2014","journal-title":"Eur J Appl Physiol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.011_bib0157","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:40:04Z","timestamp":1760607604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":157,"alternative-id":["S0953620523002078"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.06.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}